Dermal Source Inc News Today

The FDA has issued warning letters to 6 companies for selling unapproved, misbranded, OTC analgesic products that are marketed for topical use to relieve pain before, during or after certain cosmetic procedures.

Certain topical pain relief products that contain high amounts of lidocaine could lead to serious health effects such as seizures, irregular heartbeat and difficulty breathing.

Certain topical pain relief products that contain high amounts of lidocaine could lead to serious health effects such as seizures, irregular heartbeat and difficulty breathing.

Certain topical pain relief products that contain high amounts of lidocaine could lead to serious health effects such as seizures, irregular heartbeat and difficulty breathing.

FDA warning, medical aesthetics, OTC products, pain medication, topical medication

Some of these OTC analgesic products may contain concentrations of lidocaine that are higher than what is permitted, which may put consumers at risk for serious injury.

Six companies were sent warning letters from the FDA, after it discovered the companies' creams and gels contain Lidocaine at concentrations that are higher than legally permitted in over-the-counter products, the agency said.

The U.S. Food and Drug Administration has warned against certain over-the-counter analgesic or pain relief products by six companies citing potential for dangerous health effects.

The pain relievers are used before, during, or after certain procedures.

The agency warns consumers against using these products, which are marketed for topical use to relieve pain associated with cosmetic procedures.